Walled-off pancreatic necrosis (WON) is associated with a mortality of 20-30%. The current evidence supports a minimally invasive drainage approach to infected WON. The current suggested approach in international guidelines is the endoscopic step-up approach. However, recent evidence from large national cohorts support the use of direct endoscopic necrosectomy (DEN) at the time of stent placement, resulting in earlier resolution of WON and less number of necrosectomies. This study aims to investigate the clinical outcomes of the DEN versus the step-up approach for necrosectomy after endoscopic drainage of WON.
INTRODUCTION Acute pancreatitis is one of the most common gastrointestinal diseases requiring emergency admissions to the hospital. 10-20% of these patients develop pancreatic necrosis and subsequent walled-off pancreatic necrosis (WON) and is associated with a mortality of 20-30%. Grade 1A evidence exists to support an initial minimally invasive drainage approach to infected WON. However, the optimal approach and timing of necrosectomy remains unaddressed. The current suggested approach in international guidelines is the endoscopic step-up approach. However, recent evidence from large national cohorts support the use of direct endoscopic necrosectomy (DEN) at the time of stent placement, resulting in earlier resolution of WON and less number of necrosectomies. OBJECTIVE This study aims to investigate the clinical outcomes of the DEN versus the step-up approach for necrosectomy after endoscopic drainage of WON. HYPOTHESIS The hypothesis is that DEN at the time of LAMS placement improves clinical outcomes after endoscopic drainage of WON as compared to the endoscopic step-up approach. DESIGN AND SUBJECTS This is a multicentre international randomized controlled trial. Patients with suspected or confirmed infected or symptomatic WON on computed tomography (CT) and who are deemed feasible for endoscopic drainage will be included in the study. Endoscopic drainage with lumen-apposing metal stents (LAMS) will be performed. Patients will be randomised to either the endoscopic step-up approach or direct endoscopic necrosectomy (DEN) approach. The primary endpoint is a composite of major complications or death within 6 months after randomisation. Secondary endpoints include time to resolution of WON, pancreatic functions, biliary strictures, need for necrosectomy, total number of interventions, length of hospital and ICU stay, recurrence of WON and unplanned readmissions related to WON. A reduction in cumulative primary endpoint with the DEN approach by 22.4% (32.2% to 9.8%) in comparison to endoscopic step-up approach was assumed. With a 2-sided significance level of 5% and power of 80%, taking into account a 5% drop-out rate, a total of 108 patients was required to demonstrate this effect. Study collaboration has been established with four other international centres. A estimation of 3 years is required to complete study recruitment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
108
Endoscopic necrosectomy will be performed with a forward-viewing gastroscope into the WON cavity. Debridement of necrotic tissue will be performed with irrigation and/or mechanical removal with endoscopic instruments. For this arm, step up approach will be adopted.
Endoscopic necrosectomy will be performed with a forward-viewing gastroscope into the WON cavity. Debridement of necrotic tissue will be performed with irrigation and/or mechanical removal with endoscopic instruments. For this arm, the direct approach will be adopted.
Royal Adelaide Hospital
Adelaide, Australia
RECRUITINGThe Chinese University of Hong Kong
Hong Kong, Hong Kong
RECRUITINGMedanta Institute Of Digestive & Hepatobiliary Sciences
Haryāna, India
RECRUITINGAsian Institute of Gastroenterology
Hyderabad, India
RECRUITINGDeenanath Mangeshkar Hospital & Research Centre
Pune, India
RECRUITINGAsan Medical Centre
Asan, South Korea
RECRUITINGSoonChunHyang University School of Medicine
Asan, South Korea
RECRUITINGHospital Universitario Rio Hortega
Valladolid, Spain
RECRUITINGKing Chulalongkorn Memorial Hospital
Bangkok, Thailand
RECRUITINGA composite of major complications or death within 6 months after randomisation
Major complications include new onset multi-organ failure, multiple organ failure, persistent organ failure, bleeding requiring intervention, perforation of visceral organ requiring intervention, gas embolism
Time frame: 6 months
The individual components of the primary endpoint
The individual components include new onset multi-organ failure, multiple organ failure, persistent organ failure, bleeding requiring intervention, perforation of visceral organ requiring intervention, gas embolism
Time frame: 6 months
Time to resolution of WOPN
LAMS insertion to LAMS removal
Time frame: 6 months
Exocrine pancreatic insufficiency
Exocrine pancreatic insufficiency defined as Oral pancreatic-enzyme supplementation required to treat clinical symptoms of steatorrhea 6 months after randomization; this requirement was not present before onset of acute pancreatitis
Time frame: 6 months
Biliary strictures
Presence of biliary strictures on cholangiogram/ CT/ MRI
Time frame: 6 months
Total no. of interventions
The total number of interventions including necrosectomy or other surgical/ radiological interventions
Time frame: 6 months
Length of hospital
The total length of hospital stay
Time frame: 6 months
Recurrence of WOPN
The recurrence of WOPN detected on imaging (CT/ USG/ MRI/ EUS)
Time frame: 6 months
Unplanned readmissions related to WOPN
The no. of unplanned readmissions related to WOPN
Time frame: 6 months
Endocrine pancreatic insufficiency
Insulin or oral antidiabetic drugs required 6 months after randomization; this requirement was not present before onset of acute pancreatitis
Time frame: 6 months
The no. of necrosectomies
The number of necrosectomies required
Time frame: 6 months
Total ICU stay
No. of days for ICU stay
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.